Cytokines in immunity;Cytokiny w procesach odpornościowych

Onkologia Polska

Volumn 8, Issue 4, 2005, Pages 217-222

  Kopeć Szlȩzak, Joanna ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

Cytokines; Immunity; Immunotherapy; Interleukines

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 19; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7; INTERLEUKIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; DENDRITIC CELL; HUMAN; INNATE IMMUNITY; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; PHAGOCYTOSIS; PROMOTER REGION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 33644954767     PISSN: 15056732     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Abbas A., Lichtman A.: Cytokines. [w:] Cellular and molecular immunology. Elsevier Sannders, Philadelphia 2005, 243-274.
2. Vaday G.G., Lider O.: Extracellular matrix moieties, cytokines, and enzymes: dynamic effect on immune cell behavior and inflammation. J. Leukoc. Biol. 2000, 67, 149-159
3. Kopeć-Szlezak J.: Subpopulacje limfocytów T. Onkol. Pol. 2005, 8, 17-20.
4. Bolandor F.F.: Molecular endocrinology. Acad. Press Elsevier, Amsterdam 2004.
5. Kang J., Der S.D.: Cytokine functions in the formative stages of a lymphocyte's life. Curr. Opin. Immunol. 2004, 16, 180-190.
6. Reddy P.: IL-18: recent advances. Curr. Opin. Hematol. 2004, 11, 405-410.
7. Watford W.T., Moriguchi M., Morinobu A., O'Shea J.J.: The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 2003, 14, 361-368.
8. Langrish C.L., Mckenzie B.S., Wilson N.J. i wsp.: IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 2004, 202, 96-105.
9. Fal M., Gościcka T.: lnterleukina 18. Post. Hig. Med. Dośw. 2003, 57, 685-609.
10. Conti P., Kempuraj D., Frydas S. i wsp.: T.C.: IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26. Immunol. Lett. 2003, 88, 171-174.
11. Dias S., Silva H. Jr, Cumano A., Vieira P.: Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. J. Exp. Med. 2005, 201, 971-979.
12. Benczik M., Gaffen S.L.: The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol. Invest. 2004, 33, 109-142.
13. Ivashkiv LB.: Jak-STAT signaling pathways in cells of the immune system. Rev. Immunogenet. 2000, 2, 220-230.
14. Wang M., Liang P.: Interleukin-24 and its receptors. Immunology 2005, 114, 166-171.
15. Sheikh F., Baurin V.V., Lewis-Antes A. i wsp.: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J. Immunol. 2004, 172, 2006-2010.
16. Schluns KS., Lefrancois L.: Cytokine control of memory T-cell development and survival. Nature Rev. Immunol. 2003, 3, 269-279.
17. Fuller M.J., Hildeman D.A., Sabbaj S. i wsp.: Cutting edge: emergence of CD127high functionaly competent memory T cells is compromised by high viral loads and inadequate T cell help. J. Immunol. 2005, 15, 5926-5930.
18. Zdanov A.: Structural features of the interleukin-10 family of cytokines. Curr. Pharm. Des. 2004, 10, 3873-3884.
19. Lucas S., Ghilardi N., Li J, de Sauvage F.J.: IL-27 regulates IL-12 responsiveness of native CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 2003, 100, 15047-15052.
20. Bień E., Balcerska E.: Interleukin-2 receptor the structure, function and clinical significance in malignant diseases of adults and children. Post. Med. Hig. 2003, 57, 669-683.
21. Waldmann T.A.: Targeting the IL-15/IL-15R system in inflammantory autoimmune diseases. Arthritis. Res. Ther. 2004, 6, 174-177.
22. Ueda M., Imada K., Imura A. i wsp.: Expression of functional interleukin-21 receptor on adult T-cell Ieukaemia cells. Br. J. Haematol. 2005, 128, 169-176.
23. Vu M.D, Li X.C.: The common gamma-cytokines and transplantation tolerance. Arch. Immunol. Ther. Exp. 2004, 52, 267-273.
24. Jacobsohn D.A., Vogelsang G.B.: Anti-cytokine therapy for the treatment of graft-versus-host disease. Curr. Pharm. Des. 2004, 10, 1195-1205.
25. b-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy. Br. J. Haematol. 2004, 127, 531-542.
26. Lotze M.T., Herberman RB.: NK cells are central to the immune response and immunotherapy of patients with cancer. Enhancer 2004, 2, 2-8.
27. Al-Rawi M.A., Mansel R.E., Jiang W.G.: Interleukin-7 (IL-7) and receptor (IL-7R) signalling complex in human solid tumors. Histol. Histopathol. 2003, 18, 911-923.
28. Lee S.J.: New approaches for preventing and treating chronic graft-versus-host disease. Blood 2005, 105, 4200-4206.
29. Cordoba-Rodriguez R., Frucht D.M.: IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics. Exp. Opin. Biol. Ther. 2003, 3, 715-723.
30. Gadina M., Ferguson P.R., Johnston J.A.: New interleukins: are there any more? Curr. Opin. Infect. Dis. 2003, 16, 211-217.